CYP19A1 and breast cancer: Particularly, genistein has been shown to obstruct the inhibitory activities of aromatase inhibitors, including letrozole [249] and fadrozole [248] against growth of MCF-7 breast cancer cells in a xenograft model and in vitro, respectively.